Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative negative emotions and cognitive dysfunction after thoracic surgery
ChiCTR2100047067Phase 4Recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain, postoperative delirium (POD), anxiety disorder and 2 more (3 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Visual analogue scale, Confusion Assessment Method and 2 more. Started Jan 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painpostoperative delirium (POD)anxiety disorderpostoperative depressionpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2100047067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047067.